Sanofi's venture arm backs 'digital' drug startup Click Therapeutics
Sanofi Ventures, the Cambridge-based venture capital arm of French drugmaker Sanofi (NYSE: SNY), led a $17 million round on Monday for a New York startup that is creating digital tools to help people quit smoking, manage chronic pain and treat other disorders.
Click Therapeutics, which was founded in 2012, is part of the emerging field of "digital therapeutics." The company launched a smoking cessation app called Clickotine last year and is developing digital treatments for depression, insomnia,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news
More News: Chronic Pain | Depression | France Health | Health Management | Insomnia | Pain | Pharmaceuticals | Smokers | Venture Capital